SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTION LTE LONG-TERM EXTENSION STUDY

Stefan Schreiber  1     Mamoru Watanabe  2     Chohee Yun  3     Yan Zhou  3     Sally Zhao  3     Jeremy Hsieh  3     Ulrik Moerch  4     Gerhard Rogler  5     Edward V Loftus Jr  6    
1 University Hospital Schleswig-Holstein, Kiel, Germany
2 Tokyo Medical and Dental University, Tokyo, Japan
3 Gilead Sciences, Inc., Foster City, United States
4 Gilead Sciences, Inc., Copenhagen, Denmark
5 University of Zurich, Zurich, Switzerland
6 Mayo Clinic College of Medicine, Rochester, Minnesota, United States

Topic
IBD, Paediatrics

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing